iCAD’s Xoft Brain IORT Demonstrates Significant Improvement in Overall Survival in Recurrent Glioblastoma According to Comparative Study
Patients treated with Xoft Brain IORT lived for a range of 4 to 54 months after treatment without recurrence, whereas...